Journal
DIABETOLOGY & METABOLIC SYNDROME
Volume 5, Issue -, Pages -Publisher
BMC
DOI: 10.1186/1758-5996-5-24
Keywords
Lipidomics; Obesity; Dyslipidemia; Endothelial cells; Oxidized phospholipids
Categories
Funding
- CSU Proteomics and Metabolomics Facility Academic Enrichment Program
Ask authors/readers for more resources
Background: Lipidomic analysis was performed to explore differences in lipid profiles between plasma from lean and obese subjects, followed by in vitro methods to examine a role for the identified lipids in endothelial cell pathophysiology. Methods: Plasma was collected from 15 morbidly obese and 13 control subjects. Lipids were extracted from plasma and analyzed using LC/MS, and MS/MS to characterize lipid profiles and identify lipids that are elevated in obese subjects compared to lean. Results: Orthogonal partial least squares-discriminant analysis (OPLS-DA) modelling showed that lipid profiles were significantly different in obese subjects compared to lean. Analysis of lipids that were driving group separation in the OPLS-DA model and that were significantly elevated in the obese group led to identification of a group of ether-linked phosphatidylcholine (PC) and phosphatidylethanolamine (PE) lipids of interest. Treatment of human coronary artery endothelial cells with the ether-linked phosphatidylethanolamine induced expression of cell adhesion molecules, a hallmark of endothelial cell activation. However, oxidized phosphatidylcholine products that can induce endothelial cell activation in vitro, were not significantly different between groups in vivo. Conclusion: These data suggest a role for ether-linked lipids in obesity associated dyslipidemia and vascular disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available